125 related articles for article (PubMed ID: 36972629)
1. Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.
Jeon HM; Oh YT; Shin YJ; Chang N; Kim D; Woo D; Yeup Y; Joo KM; Jo H; Yang H; Lee JK; Kang W; Sa J; Lee WJ; Hale J; Lathia JD; Purow B; Park MJ; Park JB; Nam DH; Lee J
Neoplasia; 2023 May; 39():100894. PubMed ID: 36972629
[TBL] [Abstract][Full Text] [Related]
2. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
Prabhu VV; Madhukar NS; Gilvary C; Kline CLB; Oster S; El-Deiry WS; Elemento O; Doherty F; VanEngelenburg A; Durrant J; Tarapore RS; Deacon S; Charter N; Jung J; Park DM; Gilbert MR; Rusert J; Wechsler-Reya R; Arrillaga-Romany I; Batchelor TT; Wen PY; Oster W; Allen JE
Clin Cancer Res; 2019 Apr; 25(7):2305-2313. PubMed ID: 30559168
[TBL] [Abstract][Full Text] [Related]
3. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.
Caragher SP; Shireman JM; Huang M; Miska J; Atashi F; Baisiwala S; Hong Park C; Saathoff MR; Warnke L; Xiao T; Lesniak MS; James CD; Meltzer H; Tryba AK; Ahmed AU
J Neurosci; 2019 Mar; 39(11):1982-1993. PubMed ID: 30651332
[TBL] [Abstract][Full Text] [Related]
4. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
5. The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.
Weissenrieder JS; Reed JL; Green MV; Moldovan GL; Koubek EJ; Neighbors JD; Hohl RJ
Pharmacology; 2020; 105(1-2):19-27. PubMed ID: 31645049
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.
Li J; Zhu S; Kozono D; Ng K; Futalan D; Shen Y; Akers JC; Steed T; Kushwaha D; Schlabach M; Carter BS; Kwon CH; Furnari F; Cavenee W; Elledge S; Chen CC
Oncotarget; 2014 Feb; 5(4):882-93. PubMed ID: 24658464
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.
He Y; Li J; Koga T; Ma J; Dhawan S; Suzuki Y; Furnari F; Prabhu VV; Allen JE; Chen CC
Neuro Oncol; 2021 Mar; 23(3):400-411. PubMed ID: 32830856
[TBL] [Abstract][Full Text] [Related]
8. Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop.
Wang Y; Wang X; Wang K; Qi J; Zhang Y; Wang X; Zhang L; Zhou Y; Gu L; Yu R; Zhou X
J Exp Clin Cancer Res; 2023 Jul; 42(1):161. PubMed ID: 37415171
[TBL] [Abstract][Full Text] [Related]
9. Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma.
He L; Bhat K; Ioannidis A; Zhang L; Nguyen NT; Allen JE; Nghiemphu PL; Cloughesy TF; Liau LM; Kornblum HI; Pajonk F
Radiother Oncol; 2021 Aug; 161():140-147. PubMed ID: 34097975
[TBL] [Abstract][Full Text] [Related]
10. Role of Dopamine Receptors in the Anticancer Activity of ONC201.
Kline CLB; Ralff MD; Lulla AR; Wagner JM; Abbosh PH; Dicker DT; Allen JE; El-Deiry WS
Neoplasia; 2018 Jan; 20(1):80-91. PubMed ID: 29216597
[TBL] [Abstract][Full Text] [Related]
11. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
12. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
Bhere D; Tamura K; Wakimoto H; Choi SH; Purow B; Debatisse J; Shah K
Neuro Oncol; 2018 Jan; 20(2):215-224. PubMed ID: 29016934
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W
Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693
[TBL] [Abstract][Full Text] [Related]
15. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
Shi L; Chen H; Chen K; Zhong C; Song C; Huang Y; Wang T; Chen L; Li C; Huang A; Qi S; Li H; Lu Y
Clin Cancer Res; 2023 Aug; 29(16):3172-3188. PubMed ID: 37249604
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.
Iizuka Y; Sei Y; Weinberger DR; Straub RE
J Neurosci; 2007 Nov; 27(45):12390-5. PubMed ID: 17989303
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D
Weissenrieder JS; Reed JL; Moldovan GL; Johnson MT; Trebak M; Neighbors JD; Mailman RB; Hohl RJ
Pharmacol Res Perspect; 2021 May; 9(3):e00689. PubMed ID: 34003586
[TBL] [Abstract][Full Text] [Related]
18. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
[TBL] [Abstract][Full Text] [Related]
19. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.
Redjal N; Zhu Y; Shah K
Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.
Lee H; Shim S; Kong JS; Kim MJ; Park S; Lee SS; Kim A
Cancer Sci; 2021 Sep; 112(9):3732-3743. PubMed ID: 34118099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]